TRUMP'S EPA DEFIES SCIENCE, PROPOSES NEW APPROVAL OF GLYPHOSATE | WHAT REALLY HAPPENED

TRUMP'S EPA DEFIES SCIENCE, PROPOSES NEW APPROVAL OF GLYPHOSATE

Yesterday, the U.S. Environmental Protection Agency (EPA) issued a "proposed interim decision" on glyphosate's registration review, denying the pesticide's widely-accepted carcinogenic threat, while leaving leaving several critical assessments unfinished.

In 2015, the World Health Organization's International Agency for Research on Cancer (IARC) found glyphosate to be a probable human carcinogen, a determination supported by the medical science community. The State of California also lists glyphosate as a carcinogen under Prop 65. Juries have decided in favor of two cancer victims who sued Monsanto, a major glyphosate manufacturer, for failing to warn of the cancer risk posed by the company's glyphosate-based herbicides, and awarded them roughly $80 million each. Over 11,000 additional plaintiffs have similar cases pending. Monsanto was recently acquired by the German corporation Bayer.

"EPA and Monsanto continue to defy the science, and deny glyphosate's carcinogenic threat," said Bill Freese, Science Policy Analyst at Center for Food Safety. "Trump's EPA is apparently twisting the science in a vain attempt to help Monsanto defend itself against the many pending glyphosate-cancer lawsuits," he added.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA